Incidence & management practices of snakebite: A retrospective study at Sub-District Hospital, Dahanu, Maharashtra, India
Autor: | Pratibha Kokate, Smita D. Mahale, Shagufta A. Khan, Rahul K. Gajbhiye, Iranna Mashal, Arun Yadav, Sanjay Bodade, Sunita Kharat |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Adult Male medicine.medical_specialty Adolescent annual incidence - anti-snake venom - envenomation - snakebite - venomous 030106 microbiology Population Poison control India Snake Bites lcsh:Medicine snakebite General Biochemistry Genetics and Molecular Biology Annual incidence 03 medical and health sciences Young Adult 0302 clinical medicine Case fatality rate Medicine Humans 030212 general & internal medicine education Envenomation Child Management practices Aged Retrospective Studies education.field_of_study envenomation business.industry Antivenins Incidence (epidemiology) Incidence lcsh:R Infant Retrospective cohort study General Medicine Middle Aged Hospitals District venomous anti-snake venom Child Preschool Emergency medicine Female Original Article business |
Zdroj: | Indian Journal of Medical Research, Vol 150, Iss 4, Pp 412-416 (2019) The Indian Journal of Medical Research |
ISSN: | 0971-5916 |
Popis: | This study was undertaken to know the incidence and management practices of snakebite envenomation at the First Referral Unit - Sub-District Hospital, Dahanu, Maharashtra, India. Retrospective analysis of snakebite case records (n=145) was carried out for one-year period (January to December 2014). The annual incidence of snakebite was 36 per 100,000 population with case fatality rate of 4.5 per cent. Venomous snakebites were 76 per cent and non-venomous snakebites were 24 per cent. Overall, snakebites were more common in males (52.4%) than females (47.6%). Majority of the snakebites (66%) were in the age group of 18-45 yr. Seasonal variation was observed with highest snakebites in monsoon (58%). Lower extremities were the most common site of bites (63%). Neurotoxic and vasculotoxic envenomation were reported in 19 and 27 per cent snakebite cases, respectively. Anti-snake venom (ASV) was administered at an average dose of 7.5±0.63 vials (range 2-40, median 6). There was no uniform protocol followed for ASV administration as per the National Snakebite Management Protocol of Government of India (2009). |
Databáze: | OpenAIRE |
Externí odkaz: |